Logo do repositório
 
Publicação

Psychedelic treatments for mental health conditions pose challenges for informed consent

dc.contributor.authorSeybert, Carolina
dc.contributor.authorCotovio, Gonçalo
dc.contributor.authorMadeira, Luis
dc.contributor.authorRicou, Miguel
dc.contributor.authorPires, Ana Matos
dc.contributor.authorOliveira-Maia, Albino J.
dc.date.accessioned2023-06-16T13:53:43Z
dc.date.available2023-06-16T13:53:43Z
dc.date.issued2023
dc.descriptionCopyright © 2023, Springer Nature America, Inc.pt_PT
dc.description.abstractIn past years, clinical trials with psychedelic substances have been conducted to find alternative treatments for hard-to-treat mental health conditions such as treatment-resistant depression, cancer-related depression and anxiety symptoms and post-traumatic stress disorder. Clinical research has advanced under the regulation of national ethical and medication authorities for clinical trials, much as for any study testing a new intervention. Indeed, recent research on psychedelics has been conducted under the protected conditions of clinical trials, following international guidelines. However, psychedelic treatments present unique ethical and regulatory challenges that may not have been fully addressed within the traditional structures of clinical trial regulation. These challenges need to be addressed before these substances are approved for use in general clinical practice.pt_PT
dc.description.sponsorshipThis work was supported by grant PTDC/MED-NEU/31331/2017 from the Fundação para a Ciência e Tecnologia to C.S., G.C. and A.J.O.-M. A.J.O.-M. received other grants from the Fundação para Ciência e Tecnologia (PTDC/SAU-NUT/3507/2021; PTDC/MED-NEU/1552/2021) and the Fundação para Ciência e Tecnologia and FEDER (PTDC/MED-NEU/30845/2017_LISBOA-01-0145-FEDER-030845; PTDC/MEC-PSQ/30302/2017_LISBOA-01-0145-FEDER-30302), a Starting Grant from the European Research Council (grant agreement no. 950357) and grants from the European Union’s Horizon 2020 research and innovation program (H2020‑SC1‑2017‑CNECT‑2‑777167‑ΒΟUNCE; H2020‑SC1‑DTH‑2019‑875358‑FAITH) and the European Joint Programme in Rare Diseases (Joint Translational Call 2019) through the Fundação para Ciência e Tecnologia (EJPRD/0001/2020).pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationNat Med. 2023 Jun 14pt_PT
dc.identifier.doi10.1038/s41591-023-02378-5pt_PT
dc.identifier.eissn1546-170X
dc.identifier.issn1078-8956
dc.identifier.urihttp://hdl.handle.net/10451/58253
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherSpringer Naturept_PT
dc.relationLISBOA-01-0145-FEDER-030845pt_PT
dc.relationViscerosensorial patwhays in nutrient postingestive signalling
dc.relationH2020‑SC1‑2017‑CNECT‑2‑777167‑ΒΟUNCEpt_PT
dc.relationH2020‑SC1‑DTH‑2019‑875358‑FAITHpt_PT
dc.relationReinforcement learning from post-ingestive calories: from body to brain in health and disease
dc.relationNovel therapeutic approaches to target GNE Myopathy
dc.relation.publisherversionhttps://www.nature.com/nm/pt_PT
dc.titlePsychedelic treatments for mental health conditions pose challenges for informed consentpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardNumberPTDC/MED-NEU/31331/2017
oaire.awardNumberPTDC/SAU-NUT/3507/2021
oaire.awardNumberPTDC/MED-NEU/1552/2021
oaire.awardNumberPTDC/MED-NEU/30845/2017
oaire.awardNumberPTDC/MEC-PSQ/30302/2017
oaire.awardNumber950357
oaire.awardNumberEJPRD/0001/2020
oaire.awardTitleViscerosensorial patwhays in nutrient postingestive signalling
oaire.awardTitleReinforcement learning from post-ingestive calories: from body to brain in health and disease
oaire.awardTitleNovel therapeutic approaches to target GNE Myopathy
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FMED-NEU%2F31331%2F2017/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FSAU-NUT%2F3507%2F2021/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FMED-NEU%2F1552%2F2021/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/9471 - RIDTI/PTDC%2FMED-NEU%2F30845%2F2017/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/9471 - RIDTI/PTDC%2FMEC-PSQ%2F30302%2F2017/PT
oaire.awardURIinfo:eu-repo/grantAgreement/EC/H2020/950357/EU
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/3599-PPCDT/EJPRD%2F0001%2F2020/PT
oaire.citation.titleNature Medicinept_PT
oaire.fundingStream3599-PPCDT
oaire.fundingStream3599-PPCDT
oaire.fundingStream3599-PPCDT
oaire.fundingStream9471 - RIDTI
oaire.fundingStream9471 - RIDTI
oaire.fundingStreamH2020
oaire.fundingStream3599-PPCDT
person.familyNameAntónio Proença Duarte Madeira
person.givenNameLuis
person.identifier.ciencia-id0113-501B-8502
person.identifier.orcid0000-0003-2718-9758
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100008530
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameEuropean Commission
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsrestrictedAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication77f34159-aa27-434e-af43-59cde9faf2a9
relation.isAuthorOfPublication.latestForDiscovery77f34159-aa27-434e-af43-59cde9faf2a9
relation.isProjectOfPublication2dd007da-2399-41d2-9dc5-028dc92c89dd
relation.isProjectOfPublication65ed1acc-b2ef-4c3d-a149-8319cdad16d1
relation.isProjectOfPublicationd6cba5d9-2394-4dc5-b1d0-8625a1fa886b
relation.isProjectOfPublication54bdbae8-d63c-4340-94cb-e63c48ddd740
relation.isProjectOfPublication1a23843e-06c1-49a6-ae82-f6065af89283
relation.isProjectOfPublication63f32b38-2b8f-4530-abbb-73ac1a5bbeef
relation.isProjectOfPublication586a1393-37d2-45d4-aea8-1d17dc867462
relation.isProjectOfPublication.latestForDiscovery1a23843e-06c1-49a6-ae82-f6065af89283

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
Psychedelic_informed.pdf
Tamanho:
1 MB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.2 KB
Formato:
Item-specific license agreed upon to submission
Descrição: